Navigation Links
Bretylium, Serum or Plasma

ProductsBretylium, Serum or Plasma
Company ARUP Laboratories
Item Bretylium, Serum or Plasma
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. Bretylium, Urine
2. SAFE-T-FILL Serum
3. SAFE-T-FILL Serum Mini Capillary Collection Tubes
4. SAFE-T-FILL Serum Gel Mini Capillary Collection Tubes
5. SAFE-T-FILL Serum Gel Capillary Collection Tubes
6. SAFE-T-FILL Serum Bili
7. SAFE-T-FILL Serum Bili Gel Capillary Collection Tubes
8. Lyphochek Maternal Serum Control
9. Liquichek Serum Volatiles Control
10. Lyphochek Drug-Free Serum
11. hCG Combo Urine/Serum - Rapid Test
The BladderScan BVM 6500 enables physicians quickly and noninvasively to determine UEBW (ultrasound estimated bladder weight) and bladder volume using 3-dimensional V-mode ultrasound. The BVM 6500 wa
... leading bulking therapy, is the least invasive im...ncontinence (SUI). Natural collagen protein adds b...on in a defective internal sphincter. Compatible w...en Implant forms a soft network of fibers, inducin...
The Titan™ Inflatable Penile Prosthesis (IPP) is a hydraulic system designed to be surgically implanted into the penis for the management of erectile dysfunction (also known as impotence). This
...e penile prostheses offer easy-to-use, low-cost op...ed dexterity. These implants are always rigid, but...them in an erect or concealed position. Designed t...se and to not interfere with pleasurable sensation...
Medicine Products:
(Date:10/7/2008)...ASHINGTON, Oct. 7 /PRNewswire-USNewswire/ -- The C...HA) -- in conjunction with Catholic,Health Initiat...gton, MA;,and Trinity Health, Novi, MI -- is launc...ut global climate change., Through receipt of a $...ip for the Environment (NRPE) and the Catholic Coa...
(Date:10/7/2008)...http://www.boomj.com Featuring Daily Articles on ...n and Charities, HENDERSON, Nev., Oct. 7 /PRNewsw... BOMJ) http://www.BOOMj.com, the leading social ...ver the age of 35 today announced,its commitment t... (Logo: http://www.newscom.com/cgi-bin/prnh/20070...
(Date:10/7/2008)...NTONY, France, October 7 /PRNewswire-FirstCall/ --...entered into an exclusive agreement with,Catalent ...renaline,autoinjector, ADREFLEX(R), co-developed a...se PLC., ADREFLEX(R) consists of a syringe pre-fi...adult and paediatric use (0.3 and 0.15 mg), in an,...
(Date:10/7/2008)...ITTSBURGH, Oct. 7 /PRNewswire/ -- MED3OOO Group, I...agement and technology products and,services for p...Hoffman to,the position of Chief Compliance and Et...ce in healthcare which includes over 10 years in,h...s role, Ms. Hoffman will be responsible for the ov...
Breaking Medicine News(10 mins):Health News:Catholic Health Organizations Launch Ministry-Wide Effort to Raise Awareness About Global Climate Change 2Health News:BOOMj, Inc. Joins Fight Against Breast Cancer 2Health News:BOOMj, Inc. Joins Fight Against Breast Cancer 3Health News:Stallergenes Partners With Catalent and the Medical House for Commercialization of Adrenaline Autoinjector in Europe 2Health News:MED3OOO Appoints Angela Hoffman as Chief Compliance Officer 2
...nday that surgery greatly increases a patient's ch... cancer has spread by the time a woman is diagnose...e world were simply offered palliative care, to he...them comfortable while they wait to die, surgery c...
...King's Center for Military Health Research at King...ning from Iraq are suffering from health problems....g whether there had been an increase in ill health... are comparing the mental and physical health of f...
... injured nerve fibres in the mature central nervou...hers worldwide, //but researchers at Children’s Ho...g growth factor Oncomodulin which could well be an... glaucoma, tumors, trauma, spinal cord injury and ...
... by the Oregon Health & Science University Cancer ...l in the study of the often devastating// head and...ducted by Xiao-Jing Wang, M.D., Ph.D., and his col...reakthrough have been published in the May 15 issu...
Other Medicine News:Health News:Surgery A Good Option Of Survival For Patients With Breast Cancer 2Health News:'Oncomodulin'- Path To Nerve Regeneration 2Health News:Mouse Model Beneficial to Study of Head and Neck Cancer 2
(Date:10/7/2008)...re-FirstCall/ - Burcon NutraScience,Corporation (T...,Supertein(TM) canola protein isolates are GRAS (G...e in a variety of food and beverage,applications. ...an,independent evaluation by a panel of qualified ...nutritional sciences, food allergies and pediatric...
(Date:10/7/2008)...wire-FirstCall/ -- CEL-SCI Corporation,(NYSE: CVM...rial Transfer,Agreement (MTA) with the National In... laboratory of Dr. Francesco M. Marincola, M.D., t...e tumor microenvironment,caused by CEL-SCI,s cance...e Infectious Disease and Immunogentics Section, De...
(Date:10/7/2008)... /- A study published in the,scientif...lf-renewal,reported that InVitria,s ( http://www....albumin) was an effective replacement to bovine se...tled, "The ground state of embryonic stem cell,sel...tim as a recombinant,albumin in place of animal-de...
(Date:10/7/2008)...RNewswire/ -- Taligen Therapeutics Inc.,today anno...s pipeline,candidates were presented at the XXII I...land. The data highlighted the candidates, efficac...diseases., "These highlighted presentations, as w...onference, reveal the deep expertise and expanding...
Breaking Medicine Technology:Burcon announces GRAS status for Puratein(R) & Supertein(TM) 2Burcon announces GRAS status for Puratein(R) & Supertein(TM) 3CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 2CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 2In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 4NIH awards Einstein multimillion dollar grant to extend studies of exceptional longevity 1443 1NIH awards Einstein multimillion dollar grant to extend studies of exceptional longevity 1443 2Home Care Agencies Responding to Patients Needs Still Have Room for Improvement 1441 1Home Care Agencies Responding to Patients Needs Still Have Room for Improvement 1441 2First Osteoporosis Study in Hip Fracture Patients Finds Once Yearly Reclast 28R 29 Prevents Additional Fractures and Improves Survival 288 1First Osteoporosis Study in Hip Fracture Patients Finds Once Yearly Reclast 28R 29 Prevents Additional Fractures and Improves Survival 288 2First Osteoporosis Study in Hip Fracture Patients Finds Once Yearly Reclast 28R 29 Prevents Additional Fractures and Improves Survival 288 3First Osteoporosis Study in Hip Fracture Patients Finds Once Yearly Reclast 28R 29 Prevents Additional Fractures and Improves Survival 288 4First Osteoporosis Study in Hip Fracture Patients Finds Once Yearly Reclast 28R 29 Prevents Additional Fractures and Improves Survival 288 5First Osteoporosis Study in Hip Fracture Patients Finds Once Yearly Reclast 28R 29 Prevents Additional Fractures and Improves Survival 288 6First Osteoporosis Study in Hip Fracture Patients Finds Once Yearly Reclast 28R 29 Prevents Additional Fractures and Improves Survival 288 7First Osteoporosis Study in Hip Fracture Patients Finds Once Yearly Reclast 28R 29 Prevents Additional Fractures and Improves Survival 288 8Directors Forum 3A PEPFAR and the Global AIDS Response 286 1Directors Forum 3A PEPFAR and the Global AIDS Response 286 2
...om placebo,controlled phase IIa study in patients ...N (Zurich), Switzerland, May 15, 2007 - Cytos Biot...sults from a multi-centre,and placebo-controlled p...03-QbG10, an immunotherapeutic product candidate f...ncluded 40 patients,suffering from mild to moderat...
...07 - Synthetic Blood,International, Inc. (OTCBB:SY...al analysis of its Phase IIa study with Oxycyte(TM... with preliminary,study results announced in Decem...rimary endpoint of increasing patients, oxygen,ten...lso show a,decrease in patient glucose and lactate...
Other Medicine Technology:Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 2Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 3Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 4Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 5Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 6Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 7Positive Statistical Analysis from Synthetic Blood's Oxycyte,Traumatic Brain Injury Trial Indicates Achievement of Primary,Endpoint 2Positive Statistical Analysis from Synthetic Blood's Oxycyte,Traumatic Brain Injury Trial Indicates Achievement of Primary,Endpoint 3